ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases... Show more
Get AI intraday alerts
A.I. Advisor
published Earnings
IMA is expected to report earnings to -91 cents per share on March 09
Q4'26
Est.
$-0.91
Q3'26
Missed
by $0.08
Q2'26
Beat
by $0.32
Q1'26
Missed
by $0.75
Q4'25
Missed
by $0.11
The last earnings report on November 09 showed earnings per share of -91 cents, missing the estimate of -82 cents. With 3.04K shares outstanding, the current market capitalization sits at 47.00M.